Literature DB >> 12751777

Thyroid autoimmunity and hypothyroidism before and during pregnancy.

Kris Poppe1, Daniel Glinoer.   

Abstract

In the present review, an attempt was made to describe current knowledge and concepts concerning the complex relationships that link thyroid autoimmunity (TAI) and hypothyroidism with female and male infertility, as well as abnormalities occurring during pregnancy, such as pregnancy loss and maternal and fetal repercussions associated with hypothyroidism. In the case of infertility, although the clinical relevance of TAI is somewhat controversial, when all available information is considered the results strongly suggest that when infertility is due to well-defined female causes, autoimmunity is involved and TAI constitutes a useful marker of the underlying immune abnormality, independently of thyroid function disorders. In the case of pregnancy loss, the vast majority of available studies clearly establish that TAI (even with no overt thyroid dysfunction) is associated with a significant increase in miscarriage risk. To find an association, however, does not imply a causal relationship, and the aetiology of increased pregnancy loss associated with TAI remains presently not completely understood. With regard to maternal repercussions during gestation, the main risk associated with TAI is the occurrence of hypothyroidism and obstetric complications (premature birth, pre-eclampsia, etc.). Thus, systematic screening of TAI and hypothyroidism during early pregnancy, monitoring of thyroid function with/without L-thyroxine treatment and follow-up during post-partum have proved helpful and important in order to manage these patients adequately. Finally, with regard to potential repercussions affecting the offspring, recent evidence suggests that thyroid maternal underfunction, even when considered mild (or subclinical), may be associated with an impairment of fetal brain development. When present only during the first half of gestation, maternal hypothyroxinaemia is a risk factor for impaired fetal brain development, due to insufficient transfer of maternal thyroid hormones to the feto-placental unit. When hypothyroidism is not restricted to the first trimester and worsens as gestation progresses (as in untreated hypothyroidism), the fetus may also be deprived of adequate amounts of thyroid hormones during later neurological maturation and development, leading to poorer school performance and lower IQ.

Entities:  

Mesh:

Year:  2003        PMID: 12751777     DOI: 10.1093/humupd/dmg012

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  48 in total

1.  Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients.

Authors:  Qiaoli Li; Guizhong Yang; Ying Wang; Xiaoping Zhang; Qing Sang; Huan Wang; Xinzhi Zhao; Qinghe Xing; Lin He; Lei Wang
Journal:  Hum Genet       Date:  2011-01-28       Impact factor: 4.132

2.  Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.

Authors:  Clarisa R Gracia; Christopher B Morse; Grace Chan; Samantha Schilling; Maureen Prewitt; Mary D Sammel; Susan J Mandel
Journal:  Fertil Steril       Date:  2012-01-18       Impact factor: 7.329

3.  Changes of activity and kinetics of certain liver and heart enzymes of hypothyroid and T(3)-treated rats.

Authors:  Urszula Czyzewska; Adam Tylicki; Magdalena Siemieniuk; Slawomir Strumilo
Journal:  J Physiol Biochem       Date:  2012-01-25       Impact factor: 4.158

4.  Most Frequently Reported Prescription Medications and Supplements in Couples Planning Pregnancy: The LIFE Study.

Authors:  Kristin Palmsten; Katrina F Flores; Christina D Chambers; Lauren A Weiss; Rajeshwari Sundaram; Germaine M Buck Louis
Journal:  Reprod Sci       Date:  2017-04-12       Impact factor: 3.060

Review 5.  Maternal Hypothyroxinemia-Induced Neurodevelopmental Impairments in the Progeny.

Authors:  Hui Min; Jing Dong; Yi Wang; Yuan Wang; Weiping Teng; Qi Xi; Jie Chen
Journal:  Mol Neurobiol       Date:  2015-02-11       Impact factor: 5.590

6.  Effect of thyroid peroxidase antibodies on thyroid-stimulating hormone reference limits in a primarily Latina population.

Authors:  Richard H Lee; Carole A Spencer; Martin N Montoro; Paola Aghajanian; T Murphy Goodwin; Erin A Miller; Ivana Petrovic; Lewis E Braverman; Jorge H Mestman
Journal:  Obstet Med       Date:  2009-11-30

7.  Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome.

Authors:  Weerasak Chonchaiya; Flora Tassone; Paul Ashwood; David Hessl; Andrea Schneider; Luis Campos; Danh V Nguyen; Randi J Hagerman
Journal:  Hum Genet       Date:  2010-09-01       Impact factor: 4.132

Review 8.  Hypothyroidism during pregnancy.

Authors:  Alejandro A Nava-Ocampo; Offie P Soldin; Gideon Koren
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275

9.  First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.

Authors:  Geralyn Lambert-Messerlian; Monica McClain; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter Bernstein; Mary E D'Alton
Journal:  Am J Obstet Gynecol       Date:  2008-07       Impact factor: 8.661

10.  Selenium and thyroid autoimmunity.

Authors:  Roberto Negro
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.